Table 4 General clinical data of different clinical grading groups for HIE.

From: The significance of glycemic variability in conjunction with lactate metabolism levels in the clinical assessment of neonatal hypoxic-ischemic encephalopathy

 

Mild

n = 20

Moderate

n = 12

Severe

n = 6

Moderate-severe

n = 18

F/χ2

P-value

Male sex, n(%)

12 (60)

8 (66.7)

4 (66.7)

12 (66.7)

0.249

0.969

Birth weight (g)

3355 ± 425

3592 ± 538

3500 ± 316

3564 ± 373

1.618

0.196

Gestational age (weeks)

38.35 ± 1.14

39.17 ± 1.03

38.83 ± 1.60

39.06 ± 1.21

1.603

0.200

Umbilical arterial cord pH

6.98 ± 0.08

6.92 ± 0.06

6.93 ± 0.05

6.93 ± 0.06

2.735

0.053

5-min Apgar (IQR)

5 (5,5)

4 (4,5)

4 (3,5)

4 (4,5)

11.520

0.003

Vaginal delivery, n(%)

11 (55.0)

5 (41.7)

4 (66.7)

9 (50.0)

1.130

0.770

Gestational hypertension, n(%)

4 (20.0)

3 (25.0)

2 (33.3)

5 (27.8)

0.563

0.905

Parenteral nutrition, n(%)

18(90.0)

12(100.0)

6(100.0)

18(100.0)

3.733

0.292

MRI scan, n(%)

15(75.0)

12(100.0)

6(100.0)

18(100.0)

9.882

0.020

Age at MRI scan (days)

4.9 ± 1.4

5.6 ± 1.4

7.0 ± 2.7

6.0 ± 2.0

2.770

0.051

Abnormalities on MRI, n(%)

13(86.7)

12(100.0)

6(100.0)

18(100.0)

4.996

0.172

  1. HIE, hypoxic-ischemic encephalopathy; MRI, magnetic resonance imaging.